Industry Information

Update May 08, 2021

The world's top 20 best-selling drugs are released! Roche's three major monoclonal antibodies fell, O drugs fell behind; macromolecular drugs accounted for half of the country...

Recently, according to Evaluate Pharma data, the Fierce Pharma website released a list of the world’s top 20 drug sales. AbbVie’s Hummer, Merck’s Kerida and Bristol-Myers Squibb’s Rui Fumei are...

Update May 07, 2021

Pfizer BCMA×CD3 double-antibody suspension patients are enrolled. How safe is the double-antibody drug?

On May 4, Pfizer announced its 2021Q1 results. The company's revenue in the first quarter reached US$14.6 billion, an increase of 42% year-on-year. The main driver of the performance was the new...

Update May 06, 2021

Revenue ranking in the CDMO field in 2020, the market share of WuXi Biologics will fall within five years

Nowadays, foreign multinational pharmaceutical companies have divested their production functions and advocated asset-light operations, which has brought about an increase in the overall outsourcing...

Update April 30, 2021

If you want to make a breakthrough in the PD-1 market under the trend of low prices, Fosun has only this set of "seven injuries"!

On April 22, Henlius's "Slulimumab injection (ie, recombinant anti-PD-1 humanized monoclonal antibody injection)" was used for unresectable or highly metastatically unresectable or highly metastatic...

Update April 29, 2021

Corning Jerry's PD-L1/CTLA-4 bispecific antibody KN046 and Pfizer Inleader(R) (Axitinib) jointly develop Phase II clinical trials

April 29, 2021/PRNewswire/--Corning Jereh Biopharmaceuticals announced that it has reached a clinical trial and drug supply cooperation with Pfizer to evaluate the combination of KN046 and Inlead®...

Update April 28, 2021

The second batch of national mining expiry contract renewals are open! These points need attention

In 2020, the renewal of the first batch of national bulk purchases has been completed. Most of the pilot cities follow the alliance's selected price. The alliance area mainly chooses to renew the...

Update April 27, 2021

World Intellectual Property Day! 10 billion anti-cancer drugs are not selected in the "Encouraged Generic Drug Catalog", and there are no corporate generics for the 2 major varieties...

The World Intellectual Property Day (TheWorldIntellectualPropertyDay) was established by the World Intellectual Property Organization on April 26, 2001. Today (April 26) is the 21st World...

Update April 26, 2021

The global pharmaceutical innovation index list is released! Eli Lilly won the championship, 4 innovative pharmaceutical companies made the list for the first time, BeiGene, Moderna...

The pharmaceutical R&D investment is large, the cycle is long, and the risk is high. How to judge the future potential of a pharmaceutical company? Innovative R&D and clinical translation...

Update April 25, 2021

Heavy! The first Chinese pharmaceutical company to submit a Seretide® generic drug application to the U.S. FDA

On April 1, the American pharmaceutical company Lannett (NYSE: LCI) issued an announcement stating that its strategic partner Respirent Pharmaceuticals has submitted Advair® Diskus® (Chinese trade...

Update April 23, 2021

Junshi Bio-PD-1 monoclonal antibody first-line treatment of esophageal cancer phase III clinical study reached the primary endpoint

On April 22, Junshi Biotechnology issued an announcement that its self-developed anti-PD-1 monoclonal antibody drug teriprizumab combined with chemotherapy for the first-line treatment of advanced...